MedPath

Comparision of Two Newer Local Anaesthetics Ropivacaine and Levobupivacaine in Cesarean Section under Spinal Anaesthesia

Phase 4
Registration Number
CTRI/2021/01/030719
Lead Sponsor
Dr N Sheliya Dainy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

pregnanat women of ae 20 to 40 years

ASA grade i and ii

gestational age more than 37 weeks

Exclusion Criteria

high risk pregnant women

kyphosis scoliosis

patients allergic to any drugs

local site lumbar area infection

patients with any systemic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ropivacaine is less <br/ ><br>efficacious than levobupivacaineTimepoint: bloodpressure values are monitored within 1minute,5 minutes and every 15 minutes
Secondary Outcome Measures
NameTimeMethod
TO DETERMINE VAS SCORE OF ANALGESIATimepoint: RESCUE ANALGESIA TIMING
© Copyright 2025. All Rights Reserved by MedPath